CUVL
Clinuvel Pharmaceuticals Ltd.
NASDAQ · Healthcare · Medical - Pharmaceuticals · AU
$5.90
+0.68%Next report
Analyst consensus
- Next report date
- Feb 23, 2027
- EPS estimate
- $0.18
- Revenue estimate
- $26.0M
Latest reported
- Last report date
- Aug 26, 2026
- EPS actual
- $0.34
- EPS estimate
- $0.35
- Revenue actual
- $41.1M
- Revenue estimate
- $42.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -3.5%
- Revenue beats (12Q)
- 0
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 26, 2026 | $0.35 | $0.34 | Miss -3.46% | $41.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 23, 2027